International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

Advancing therapies for cystic fibrosis

Hot topics
Chairs: Margarida D. Amaral (Lisbon, Portugal), Bert Arets (Utrecht, Netherlands)
Aims: This session will present insights into the novel therapeutic options for CF and the latest developments in gene and protein therapy. How these therapies can be administered in an individualised fashion will also be discussed.
Target audience: Clinicians and basic scientists.

Download all media

Treatment of patients with non-gating mutations with potentiators M. Proesmans (Leuven, Belgium)
Individual treatment of cystic fibrosis by using intestinal organoids Florijn Dekkers (Utrecht, Netherlands)